<p>Ethiopia introduced a second dose of measles containing vaccine (MCV2) in 2019 to provide further protection against measles. However, sub-optimal coverage with both MCV1 and MCV2 suggest challenges with vaccine uptake. In this qualitative study, we explored barriers to uptake of MCV2 among caregivers, community leaders, and healthcare workers (HCWs).</p>